Study finds UFE (uterine fibroid embolisation) leads to less bleeding than myomectomy
This article was originally published in Clinica
Minimally invasive uterine fibroid embolisation (UFE) is better than traditional surgical myomectomy in alleviating excessive menstrual bleeding, a major symptom of fibroids, according to the first head-to-head comparison of the two treatments.
You may also be interested in...
The Swiss giant is hoping to get seven more approvals for its blockbuster immunology drug over the next 10 years.
Cadila has filed for approval of saroglitazar for NASH in India. The drug, which could emerge as the first medicine for the indication if approved, is already being used by a million Indian patients for diabetic dyslipidemia and hypertriglyceridemia.
It has been a long and sometimes tortuous development path for Lupuzor but ImmuPharma's chief executive tells Scrip the company's faith in the lupus drug is bearing fruit.